trending Market Intelligence /marketintelligence/en/news-insights/trending/eoWmSYFS0bQq1m1Xu1BmSQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Australian Pharmaceutical sells entire shareholding in Sigma

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Australian Pharmaceutical sells entire shareholding in Sigma

Australian Pharmaceutical Industries Ltd. sold 137,264,592 shares of Sigma Healthcare Ltd. — its entire shareholding in the company.

The share sale follows a rejected takeover offer by API to acquire Rowville, Australia-based Sigma in March. The offer consisted of 0.31 of an API share and 23 Australian cents in cash per Sigma share.

Sigma, which is focused on wholesale and distribution of pharmaceutical products, previously said the offer was not in the best interests of its shareholders.

Regarding the decision to off-load its entire Sigma shareholding, API said its board decided that the strategic and commercial "fundamentals" that made the merger a compelling proposition have "significantly diminished."

Camberwell, Australia-based API engages in the wholesale distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies primarily in Australia.